Resilience of Hong Kong AdolescentsNCT03538145
Psychometric Evaluation of the Traditional Chinese Version of Resilience Scale-14
An observational study of Resilience of Hong Kong Adolescents, run by The University of Hong Kong at 1 site in Hong Kong.
Trial summary
This study will aim to translate the original RS-14 (English version) into traditional Chinese. It will then test the psychometric properties of the newly translated RS-14 to examine its factorial structure using both exploratory factor analysis (EFA) and CFA. Read more about this study
- Who is it for?
- Ages 12 to 13 yearsHealthy volunteers can take part
- Conditions the study is for
- Resilience of Hong Kong Adolescents
- How many people
- 2,900 participants
- Where
- 1 siteHong Kong
- Study dates
- 11 Oct 2017to 31 Dec 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 13 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: Form 1 students (Grade 7, 12 to 13 years of age) from six secondary schools across three major districts (Hong Kong Island, Kowloon and the New Territories) will be randomly selected and invited to participate in the proposed study.
Who may be able to join
- Form 1 students (Grade 7, 12 to 13 years of age) from six secondary schools
Who cannot join
- Those with chronic illnesses or identified cognitive or learning problems will be excluded.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Psychometric Evaluation of the Traditional Chinese Version of Resilience Scale-14 and the Assessment of the Resilience Level of Hong Kong Adolescents
This study will aim to translate the original RS-14 (English version) into traditional Chinese. It will then test the psychometric properties of the newly translated RS-14 to examine its factorial structure using both exploratory factor analysis (EFA) and CFA.
Read the detailed description
Mental health problems in adolescents reflect a global problem that is becoming more prevalent in Hong Kong. In Hong Kong, there is a significant change in family structure to small nuclear families. Children receive more attention and may even be overprotected by parents. Also, parents' great expectations for high academic achievement also contribute to the increase in mental health problems among adolescents in Hong Kong. The Polytechnic University and the Christian Family Service Centre conducted a mental health survey study of 12,518 Form 1 to Form 7 pupils from 2011 to 2014. Of the respondents, 62.1% demonstrated slight to very serious depression symptoms. Evidence has shown that depressive symptoms predict suicidal tendencies among adolescents.
Resilience effectively prevents the development of mental health problems and is associated with positive mental health outcomes in adolescents. Assessing resilience in adolescents is therefore crucial for developing a thorough understanding of their responses to stress and adversity. The literature reports various instruments used to assess resilience, such as the Connor-Davidson Resilience Scale (CD-RISC) and the Resilience Scale (RS). And translated version of RS-14 is also developed because of linguistic and cultural differences.
The proposed study will aim to translate the original RS-14 (English version) into traditional Chinese. It will then test the psychometric properties of the newly translated RS-14 to examine its factorial structure using both exploratory factor analysis (EFA) and CFA. Furthermore, using the newly validated RS-14, a survey will be conducted to assess the resilience level of a large sample group of Hong Kong Chinese adolescents.
- Conditions
- Resilience of Hong Kong Adolescents
What is being measured
The primary outcome is the main question the study is designed to answer.
Resilience level
The RS-14 is a 14-item scale measuring two factors: personal competence, and acceptance of self and life. The item is answered using a 7-point Likert scale ranging from "strongly disagree" to "strongly agree," with total possible scores ranging from 14 to 98. Higher scores indicate higher levels of resilience.
Measured: Baseline
Secondary outcomes (2)
Number of depressive symptoms
The subjects' depressive symptoms will be assessed using the Chinese version of the CES-DC. The CES-DC comprises 20 fully standardized items to evaluate depressive symptoms. All items are evaluated on a four-point self-report scale in relation to their incidence during the last week, which were scored from 0 to 3, with total possible scores ranging from 0 to 60, with higher scores indicating greater symptomatology.
Measured: Baseline
Levels of self-esteem
The subjects' self-esteem will be assessed using the Chinese version of the RSES. The RSES is designed to measure the global self-esteem of children and adolescents. The scale comprises 10 items, rated using a 4-point Likert scale ranging from 1 to 4, with total possible scores ranging from 10 to 40. Higher scores indicate higher levels of self-esteem.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 May 2018
- Study start11 Oct 2017
- Primary completion31 Dec 2017
- Study completion31 Dec 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Resilience of Hong Kong AdolescentsStudies of the same condition, open and under way.
- More trials run by The University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 2,900 participants (actual)
Sponsor and investigators
- Lead sponsor
- The University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Oi Kwan Joyce Chung, Dr, Principal investigator, The University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03538145
- Sponsor's protocol ID
- UW17-378
- Status last verified
- May 2018
- First submitted
- 15 May 2018
- Last updated
- 25 May 2018
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Chung JOK, Lam KKW, Ho KY, Cheung AT, Ho LK, Xei VW, Gibson F, Li WHC. Psychometric evaluation of the traditional Chinese version of the resilience Scale-14 and assessment of resilience in Hong Kong adolescents. Health Qual Life Outcomes. 2020 Feb 19;18(1):33. doi: 10.1186/s12955-020-01285-4.
PubMed 32075647
Study at a glance
From the registry record, last updated by the sponsor on 25 May 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Psychometric Evaluation of the Traditional Chinese Version of Resilience Scale-14 and the Assessment of the Resilience Level of Hong Kong Adolescents
- ClinicalTrials.gov ID
- NCT03538145
- Acronym / sponsor ID
- UW17-378
- Conditions
- Resilience of Hong Kong Adolescents
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,900 participants (actual)
- Lead sponsor
- The University of Hong KongUniversity, hospital or other
- Study start
- 11 Oct 2017 (actual)
- Primary completion
- 31 Dec 2017 (actual)
- Study completion
- 31 Dec 2017 (actual)
- First posted
- 25 May 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will aim to translate the original RS-14 (English version) into traditional Chinese. It will then test the psychometric properties of the newly translated RS-14 to examine its factorial structure using both exploratory factor analysis (EFA) and CFA.
Detailed description
Mental health problems in adolescents reflect a global problem that is becoming more prevalent in Hong Kong. In Hong Kong, there is a significant change in family structure to small nuclear families. Children receive more attention and may even be overprotected by parents. Also, parents' great expectations for high academic achievement also contribute to the increase in mental health problems among adolescents in Hong Kong. The Polytechnic University and the Christian Family Service Centre conducted a mental health survey study of 12,518 Form 1 to Form 7 pupils from 2011 to 2014. Of the respondents, 62.1% demonstrated slight to very serious depression symptoms. Evidence has shown that depressive symptoms predict suicidal tendencies among adolescents.
Resilience effectively prevents the development of mental health problems and is associated with positive mental health outcomes in adolescents. Assessing resilience in adolescents is therefore crucial for developing a thorough understanding of their responses to stress and adversity. The literature reports various instruments used to assess resilience, such as the Connor-Davidson Resilience Scale (CD-RISC) and the Resilience Scale (RS). And translated version of RS-14 is also developed because of linguistic and cultural differences.
The proposed study will aim to translate the original RS-14 (English version) into traditional Chinese. It will then test the psychometric properties of the newly translated RS-14 to examine its factorial structure using both exploratory factor analysis (EFA) and CFA. Furthermore, using the newly validated RS-14, a survey will be conducted to assess the resilience level of a large sample group of Hong Kong Chinese adolescents.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 12 to 13 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- Form 1 students (Grade 7, 12 to 13 years of age) from six secondary schools across three major districts (Hong Kong Island, Kowloon and the New Territories) will be randomly selected and invited to participate in the proposed study.
Key inclusion criteria (1 listed)
- Form 1 students (Grade 7, 12 to 13 years of age) from six secondary schools
Key exclusion criteria (1 listed)
- Those with chronic illnesses or identified cognitive or learning problems will be excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Resilience level
Time frame: Baseline
The RS-14 is a 14-item scale measuring two factors: personal competence, and acceptance of self and life. The item is answered using a 7-point Likert scale ranging from "strongly disagree" to "strongly agree," with total possible scores ranging from 14 to 98. Higher scores indicate higher levels of resilience.
2 secondary outcomes
Number of depressive symptoms
Time frame: Baseline
Levels of self-esteem
Time frame: Baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 May 2018.
- Derived from this study: PubMed 32075647Chung JOK, Lam KKW, Ho KY, Cheung AT, Ho LK, Xei VW, Gibson F, Li WHC. Psychometric evaluation of the traditional Chinese version of the resilience Scale-14 and assessment of resilience in Hong Kong adolescents. Health Qual Life Outcomes. 2020 Feb 19;18(1):33. doi: 10.1186/s12955-020-01285-4.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Oi Kwan Joyce Chung, Dr principal investigator
The University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Resilience of Hong Kong Adolescents, run by The University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 May 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Resilience level (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03538145, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2018.